Amelioration of premature aging in Werner syndrome stem cells by targeting SHIP/AKT pathway

Abstract Background Pathogenic or null mutations in WRN helicase is a cause of premature aging disease Werner syndrome (WS). WRN is known to protect somatic cells including adult stem cells from premature senescence. Loss of WRN in mesenchymal stem cells (MSCs) not only drives the cells to premature...

Full description

Saved in:
Bibliographic Details
Main Authors: Hei-Yin Tam, Jiaxing Liu, Tsz-Ching Yiu, Adrian On-Wah Leung, Chang Li, Shen Gu, Owen Rennert, Boxian Huang, Hoi-Hung Cheung
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Cell & Bioscience
Subjects:
Online Access:https://doi.org/10.1186/s13578-025-01355-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585376656523264
author Hei-Yin Tam
Jiaxing Liu
Tsz-Ching Yiu
Adrian On-Wah Leung
Chang Li
Shen Gu
Owen Rennert
Boxian Huang
Hoi-Hung Cheung
author_facet Hei-Yin Tam
Jiaxing Liu
Tsz-Ching Yiu
Adrian On-Wah Leung
Chang Li
Shen Gu
Owen Rennert
Boxian Huang
Hoi-Hung Cheung
author_sort Hei-Yin Tam
collection DOAJ
description Abstract Background Pathogenic or null mutations in WRN helicase is a cause of premature aging disease Werner syndrome (WS). WRN is known to protect somatic cells including adult stem cells from premature senescence. Loss of WRN in mesenchymal stem cells (MSCs) not only drives the cells to premature senescence but also significantly impairs the function of the stem cells in tissue repair or regeneration. Results In this study, we profiled the signaling pathways altered in WRN-deficient MSC and applied pharmacological method to activate the AKT signaling in these cells and examined their cellular phenotype related to aging. We found that the AKT signaling in WRN-deficient MSCs was significantly suppressed while the AKT upstream phosphatases (SHIP1/2) were upregulated. Knockdown or inhibition of SHIP1/2 could ameliorate premature senescence in WRN-deficient MSCs. Moreover, SHIP inhibition stimulated MSC proliferation and suppressed expression of pro-inflammatory cytokines IL-6 and IL-8. The stemness of WRN-deficient MSC was also improved upon pharmacological treatments with the inhibitors. Conclusions These results suggested that targeting the SHIP/AKT signaling pathway is beneficial to WRN-deficient stem cells and fibroblasts, which might be applied for improving the trophic function of MSC in, for instance, promoting angiogenesis.
format Article
id doaj-art-addc17dd55eb47f89745ff28dcf644e1
institution Kabale University
issn 2045-3701
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Cell & Bioscience
spelling doaj-art-addc17dd55eb47f89745ff28dcf644e12025-01-26T12:54:21ZengBMCCell & Bioscience2045-37012025-01-0115111410.1186/s13578-025-01355-4Amelioration of premature aging in Werner syndrome stem cells by targeting SHIP/AKT pathwayHei-Yin Tam0Jiaxing Liu1Tsz-Ching Yiu2Adrian On-Wah Leung3Chang Li4Shen Gu5Owen Rennert6Boxian Huang7Hoi-Hung Cheung8School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong KongSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong KongSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong KongSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong KongSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong KongSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong KongEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of HealthState Key Laboratory of Reproductive Medicine, Nanjing Medical UniversitySchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong KongAbstract Background Pathogenic or null mutations in WRN helicase is a cause of premature aging disease Werner syndrome (WS). WRN is known to protect somatic cells including adult stem cells from premature senescence. Loss of WRN in mesenchymal stem cells (MSCs) not only drives the cells to premature senescence but also significantly impairs the function of the stem cells in tissue repair or regeneration. Results In this study, we profiled the signaling pathways altered in WRN-deficient MSC and applied pharmacological method to activate the AKT signaling in these cells and examined their cellular phenotype related to aging. We found that the AKT signaling in WRN-deficient MSCs was significantly suppressed while the AKT upstream phosphatases (SHIP1/2) were upregulated. Knockdown or inhibition of SHIP1/2 could ameliorate premature senescence in WRN-deficient MSCs. Moreover, SHIP inhibition stimulated MSC proliferation and suppressed expression of pro-inflammatory cytokines IL-6 and IL-8. The stemness of WRN-deficient MSC was also improved upon pharmacological treatments with the inhibitors. Conclusions These results suggested that targeting the SHIP/AKT signaling pathway is beneficial to WRN-deficient stem cells and fibroblasts, which might be applied for improving the trophic function of MSC in, for instance, promoting angiogenesis.https://doi.org/10.1186/s13578-025-01355-4Werner syndromeAKT signalingSHIPSenescenceWRNMesenchymal stem cell
spellingShingle Hei-Yin Tam
Jiaxing Liu
Tsz-Ching Yiu
Adrian On-Wah Leung
Chang Li
Shen Gu
Owen Rennert
Boxian Huang
Hoi-Hung Cheung
Amelioration of premature aging in Werner syndrome stem cells by targeting SHIP/AKT pathway
Cell & Bioscience
Werner syndrome
AKT signaling
SHIP
Senescence
WRN
Mesenchymal stem cell
title Amelioration of premature aging in Werner syndrome stem cells by targeting SHIP/AKT pathway
title_full Amelioration of premature aging in Werner syndrome stem cells by targeting SHIP/AKT pathway
title_fullStr Amelioration of premature aging in Werner syndrome stem cells by targeting SHIP/AKT pathway
title_full_unstemmed Amelioration of premature aging in Werner syndrome stem cells by targeting SHIP/AKT pathway
title_short Amelioration of premature aging in Werner syndrome stem cells by targeting SHIP/AKT pathway
title_sort amelioration of premature aging in werner syndrome stem cells by targeting ship akt pathway
topic Werner syndrome
AKT signaling
SHIP
Senescence
WRN
Mesenchymal stem cell
url https://doi.org/10.1186/s13578-025-01355-4
work_keys_str_mv AT heiyintam ameliorationofprematureaginginwernersyndromestemcellsbytargetingshipaktpathway
AT jiaxingliu ameliorationofprematureaginginwernersyndromestemcellsbytargetingshipaktpathway
AT tszchingyiu ameliorationofprematureaginginwernersyndromestemcellsbytargetingshipaktpathway
AT adrianonwahleung ameliorationofprematureaginginwernersyndromestemcellsbytargetingshipaktpathway
AT changli ameliorationofprematureaginginwernersyndromestemcellsbytargetingshipaktpathway
AT shengu ameliorationofprematureaginginwernersyndromestemcellsbytargetingshipaktpathway
AT owenrennert ameliorationofprematureaginginwernersyndromestemcellsbytargetingshipaktpathway
AT boxianhuang ameliorationofprematureaginginwernersyndromestemcellsbytargetingshipaktpathway
AT hoihungcheung ameliorationofprematureaginginwernersyndromestemcellsbytargetingshipaktpathway